Managing Advanced Stages of Friedreich’s Ataxia: Challenges and Emerging Therapeutic Avenues : Episode 4
Opinion
Video
Managing Adverse Events in Novel Friedreich’s Ataxia Therapy
A key opinion leader outlines common adverse events associated with omaveloxolone treatment in Friedreich's ataxia patients and describes strategies used to manage or minimize these adverse effects.
- What adverse events are typically encountered with omaveloxolone, what strategies do you employ to mitigate or address them effectively and under what circumstances should omaveloxolone be discontinued, if at all?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Videos
Related Content
